Alexander Vogel

Dr. Alexander Vogel

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2021 in Liver Transplantation
Verified
Journal Article
Closed access
PDF file
GIGene Y. Im
Gene Y. Im
AVAlexander Vogel
Alexander Vogel
SFSander Florman
Sander Florman
JNJonathan Nahas
Jonathan Nahas
SFScott L. Friedman
Scott L. Friedman
TSThomas D. Schiano
Thomas D. Schiano

6 October 2019 in European Journal of Haematology
Verified
Journal Article
Closed access
PDF file
DTDouglas Tremblay
Douglas Tremblay
AVAlexander Vogel
Alexander Vogel
EMErin Moshier
Erin Moshier
RHRonald Hoffman
Ronald Hoffman
MKMarina Kremyanskaya
Marina Kremyanskaya
JMJohn Mascarenhas
John Mascarenhas

6 January 2019 in Case Reports in Hematology
Verified
Journal Article
Open access
PDF file
DTDouglas Tremblay
Douglas Tremblay
JPJuan Putra
Juan Putra
AVAlexander Vogel
Alexander Vogel
AWAdam Winters
Adam Winters
RHRonald Hoffman
Ronald Hoffman
JMJohn Mascarenhas
John Mascarenhas
Ruxolitinib is increasingly being utilized for the treatment of myelofibrosis and polycythemia vera, but the potential for hepatic toxicity is poorly understood. We performed a retrospective review of hepatic damage occurring in patients with myeloproliferative neoplasms receiving ruxolitinib. Relevant histologic images of liver biopsies were reviewed by an experienced liver pathologist and reported to a multidisciplinary team including hepatology and hematology. A variety of liver pathology was observed including extramedullary hematopoiesis, obliterative portal venopathy, and drug-induced liver injury. In all cases reviewed, the liver biopsy had significant treatment implications. We conclude that hepatology referral and liver biopsy in patients receiving ruxolitinib therapy with biochemical evidence of liver injury reveals a variety of etiologies which have significant treatment impact. Clinicians should be aware of the potential causes of liver damage in this population and initiate prompt referral and liver biopsy.

27 May 2024 in Life
Verified
Journal Article
Open access
PDF file
AVAlexander Vogel
Alexander Vogel
RRRebecca Roediger
Rebecca Roediger
DADagny von Ahrens
Dagny von Ahrens
BFBrett E Fortune
Brett E Fortune
JSJonathan M. Schwartz
Jonathan M. Schwartz
CTClara Y Tow
Clara Y Tow
Poor metabolic health and obesity have significant impacts on the outcomes of patients suffering from chronic liver disease, particularly those with metabolic dysfunction-associated steatotic liver disease. Patients with such comorbidities who require liver transplant evaluation for advancing liver disease or liver failure require special consideration due to increased risk of cardiovascular disease, renal dysfunction, sarcopenic obesity, and cancer. Those who have had a history of prior bariatric surgery pose specific anatomical constraints and may also be at increased risk of alcohol use disorder. Pre-operative risk assessment as well as strict control of metabolic risk factors are essential to reduce intra-operative and post-liver transplant complications. As immunosuppressive therapy exacerbates metabolic dysfunction and risk for cancer, post-liver transplant care must focus on balancing the need to prevent rejection and the impact of progressive metabolic dysfunction in this unique, but growing, patient population.

16 July 2022 in Gastro Hep Advances
Verified
Journal Article
Open access
PDF file
AVAlexander Vogel
Alexander Vogel
MLM. Li
M. Li
SZS.D. Zucker
S.D. Zucker
Download .docx (.03 MB) Help with docx files Table A1 Download .docx (.01 MB) Help with docx files Supplemental Methods Figure A1 View Large Image Figure Viewer Download Hi-res image Download (PPT)

30 November 2023 in Clinical Liver Disease
Verified
Journal Article
Closed access
TATaqwa Ahmed
Taqwa Ahmed
AVAlexander Vogel
Alexander Vogel
TOThomas Owens
Thomas Owens
FHFarrah Naz Hussain
Farrah Naz Hussain
MAMouyed Alawad
Mouyed Alawad
LGLauren T. Grinspan
Lauren T. Grinspan
Export